Skip to main content

Table 2 Clinical and radiological outcomes in both groups

From: Additional mesenchymal stem cell injection improves the outcomes of marrow stimulation combined with supramalleolar osteotomy in varus ankle osteoarthritis: short-term clinical results with second-look arthroscopic evaluation

 

Group I

Group II

P Value

VAS

   

 Preoperative

7.2 ± 1.1

7.2 ± 0.8

n.s.

 Final follow-up

4.9 ± 1.3

3.7 ± 1.5

.002

AOFAS score

   

 Preoperative

62.3 ± 6.1

61.0 ± 5.8

n.s.

 Final follow-up

81.2 ± 6.2

85.2 ± 5.2

.010

TAS, °

   

 Preoperative

82.3 ± 2.2

83.0 ± 2.1

n.s.

 Final follow-up

89.1 ± 2.1

89.4 ± 1.8

n.s.

TT, °

   

 Preoperative

5.3 ± 1.1

5.6 ± 1.4

n.s.

 Final follow-up

2.4 ± 0.9

2.8 ± 1.1

n.s.

TLS, °

   

 Preoperative

77.6 ± 1.7

76.9 ± 1.8

n.s.

 Final follow-up

79.3 ± 1.4

78.8 ± 1.8

n.s.

  1. Values are expressed as mean ± standard deviation. VAS visual analog scale, AOFAS American Orthopaedic Foot and Ankle Society ankle-hind foot scale, TAS tibial-ankle surface angle, TT talar tilt, TLS tibial-lateral surface angle